|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Pharmacology
:
Antibiotics
:
Tigecycline
Tigecycline, world�s first glycylcycline expanded broad-spectrum antibiotic, launched in UK
Tygacil (tigecycline), a new, expanded broad-spectrum IV antibiotic for the treatment of a wide range of infections including those caused by antibiotic resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), 1 will be available in the UK from 20 June 2006. Availability of this new antibiotic comes at a time when the need for effective new treatments is greater than ever and clinicians are running out of options.
Jul 22, 2006, 19:18
Latest Research
:
Pharmacology
:
Antibiotics
:
Tigecycline
FDA Approves Tigecycline, a Novel Antibiotic with Broad Spectrum of Antimicrobial Activity
The U.S. Food and Drug Administration (FDA) today approved Tygacil� (tigecycline), a novel I.V. antibiotic with a broad spectrum of antimicrobial activity, including activity against the drug-resistant bacteria methicillin-resistant Staphylococcus aureus (MRSA).
Jun 17, 2005, 20:59
|
